Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Dundee Corp T.DC.P.D


Primary Symbol: T.DC.A Alternate Symbol(s):  DNDPF | DDEJF | T.DC.P.B | DNDEF

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include Corporate and Other Portfolio Holdings; Goodman & Company, Investment Counsel Inc.; Dundee Sustainable Technologies Inc.; United Hydrocarbon International Corp., and Dundee 360 Real Estate Corporation. Corporate and Other Portfolio Holdings segment invests in public and private equity and debt securities in diversified industry segments. Goodman & Company, Investment Counsel Inc. includes the activities of Dundee Global Investment Management Inc. Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. United Hydrocarbon International Corp., an 84%-owned private subsidiary engaged in oil and gas exploration through the holding of a royalty interest in the Republic of Chad.


TSX:DC.A - Post by User

Post by HRc60to65on Aug 13, 2022 2:47pm
354 Views
Post# 34894188

Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals

Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals DC.a is holding 3.7% of TauRx Pharmaceuticals with a book value of 36.216M$CDN

In Q2-2022, DC.a is valuating TauRx at 1B$CDN.

DC.a has 88,125,373 shares issued and outstanding. 
TauRx is 0.41$/DC.a share and it is for free.

If TauRx “Lucidity” drug get positive results TauRx will do public IPO.  The TauRx value can reach 5B$US to 10B$US or 2.5$CDN to 5.0$CDN per DC.a share.

At the actual DC.a stock price of around 1.30$CDN TauRx potential is free.


<< Previous
Bullboard Posts
Next >>